This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shen, Y. Articles by Goldberg, G. S. Search for Related Content PubMed PubMed Citation Articles by Shen, Y. Articles by Goldberg, G. S.

Src Uses Cas to Suppress Fhl1 in Order to Promote Nonanchored Growth and Migration of Tumor Cells

¹ Department of Molecular Biology, University of Medicine and Dentistry of New Jersey, Stratford, New Jersey and ² Cancer Transcriptome Project, National Cancer Center Research Institute, Tokyo, Japan

Requests for reprints: Gary S. Goldberg, Department of Molecular Biology, University of Medicine and Dentistry of New Jersey, Science Center, 2 Medical Center Drive, Stratford, NJ 08084. Phone: 856-566-6718; E-mail: garygoldberg{at}comcast.net.

Anchorage independence and motility are hallmarks of tumor cell growth. Tumor cell growth and morphology can be normalized by contact with nontransformed cells. The Src tyrosine kinase phosphorylates specific sites on the focal adhesion adaptor protein Crk-associated substrate (Cas) to promote nonanchored cell growth and migration. We studied the effects of Src and Cas on the expression of >14,000 genes to identify molecular events that underlie these activities. Gene expression in tumor cells that were normalized by neighboring nontransformed cells was used as an additional filter to identify genes that control metastatic cell growth. This process enabled the identification of genes that play roles in anchorage-independent cell growth and migration. One candidate, four and a half LIM domains 1 (Fhl1), acts as a transcriptional regulator that can associate with cell junctions as well as with the nucleus. We show here that Src phosphorylates Cas to block Fhl1 expression. In addition, suppression of Fhl1 is required for Src to promote tumor cell growth. These data show that Fhl1 is a tumor suppressor gene that acts downstream of Src and Cas to specifically block anchorage-independent cell growth and migration. Moreover, Fhl1 was suppressed in tumors from several human tissues. Thus, identification of how Fhl1 controls fundamental aspects of tumor cell growth and metastasis may lead to the development of novel markers that can be used to diagnose human clinical specimens as well as open innovative avenues of investigations aimed at developing reagents that target cancer cells while minimizing damage to normal cells. (Cancer Res 2006; 66(3): 1543-52)

This article has been cited by other articles:

				R. Moral, R. Wang, I. H Russo, C. A Lamartiniere, J. Pereira, and J. Russo Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature J. Endocrinol., January 1, 2008; 196(1): 101 - 112. [Abstract] [Full Text] [PDF]

				C. Oneyama, T. Hikita, S. Nada, and M. Okada Functional dissection of transformation by c-Src and v-Src. Genes Cells, January 1, 2008; 13(1): 1 - 12. [Abstract] [Full Text] [PDF]

				Y. Shen, P. R. Khusial, X. Li, H. Ichikawa, A. P. Moreno, and G. S. Goldberg Src Utilizes Cas to Block Gap Junctional Communication Mediated by Connexin43 J. Biol. Chem., June 29, 2007; 282(26): 18914 - 18921. [Abstract] [Full Text] [PDF]

				P. Patwardhan, Y. Shen, G. S. Goldberg, and W. T. Miller Individual Cas Phosphorylation Sites Are Dispensable for Processive Phosphorylation by Src and Anchorage-independent Cell Growth J. Biol. Chem., July 28, 2006; 281(30): 20689 - 20697. [Abstract] [Full Text] [PDF]